Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DOJOLVI safely and effectively. See full prescribing information for DOJOLVI. DOJOLVI® (triheptanoin) oral liquid Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
DOJOLVI is indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
- generic_name
- triheptanoin
- product_names
- Triheptanoin
- ndc
- 69794-050, 69794-050-50
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en